SUBSCRIBE
SUBSCRIBE

Genentech, Inc.

NEWS
BioCapital
In Other (Biopharma) News: This Week’s Non-Coronavirus Stories
BioSpace takes a quick look at some recent, key industry news that is not related to the coronavirus.
March 25, 2020
 · 
4 min read
 · 
Alex Keown
BioCapital
Clinical Catch-Up: March 16-20
Here’s a look at some of last week’s clinical trial news.
March 20, 2020
 · 
7 min read
 · 
Mark Terry
Drug Development
Biopharma Industry News for March 20: Update on the Novel Coronavirus
A summary of daily Biopharma industry news. Please check out stories that are trending on March 20, 2020.
March 20, 2020
 · 
5 min read
 · 
BioSpace Editorial Staff
Drug Development
Biopharma Industry News for March 19: Update on the Novel Coronavirus
A summary of daily Biopharma industry news. Please check out stories that are trending on March 19, 2020.
March 19, 2020
 · 
3 min read
 · 
BioSpace Editorial Staff
Policy
Genentech’s Esbriet Granted Breakthrough Therapy Designation for uILD
The FDA granted the designation based on data from a mid-stage trial that examined the safety and efficacy of Esbriet in this indication.
March 4, 2020
 · 
2 min read
 · 
Alex Keown
Business
Bicycle and Genentech Forge Immuno-Oncology Collaboration Worth up to $1.7 Billion
In its announcement, Bicycle did not identify the cancer targets it will focus on in its collaboration with Genentech.
February 25, 2020
 · 
2 min read
 · 
Alex Keown
BioCapital
Team Dynamics: 15 Life Sciences Organizations Leading the Way
The most recent BioSpace Ideal Employer Report revealed the impact of team dynamics on employees within life sciences organizations.
February 24, 2020
 · 
3 min read
 · 
Porschia Parker
Employer Resources
The Top 15 Culture-Focused Life Sciences Employers
The BioSpace Ideal Employer Report examined aspects regarding the importance of culture within life sciences organizations.
February 17, 2020
 · 
3 min read
 · 
Porschia Parker
BioCapital
Clinical Catch-Up: February 10-14
It was a very busy week for clinical trial news. Here’s a look.
February 14, 2020
 · 
11 min read
 · 
Mark Terry
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
Press Releases
FDA Approves First Single-Dose Generic Treatment for Influenza
June 18, 2026
 · 
2 min read
Press Releases
FDA Grants Priority Review for Genentech’s Tecentriq for a Certain Type of Stage III Colon Cancer
June 11, 2026
 · 
14 min read
Press Releases
FDA Accepts New Drug Application for Genentech’s Giredestrant in ER-Positive Early-Stage Breast Cancer, the First and Only Oral SERD With Positive Phase III Results in the Curative Setting
June 2, 2026
 · 
7 min read
Press Releases
Genentech to Present New Data Advancing Its Obesity Portfolio at the American Diabetes Association’s 2026 Scientific Sessions
June 1, 2026
 · 
6 min read
Press Releases
Lupus Research Alliance and Genentech Fund Researchers Translating CAR T Success into Durable Lupus Treatments
May 26, 2026
 · 
5 min read
Press Releases
Genentech to Present New Data at ASCO 2026, Reinforcing Giredestrant’s Potential to Transform the Treatment Paradigm in Early Breast Cancer
May 19, 2026
 · 
19 min read
Press Releases
Roche to present new data at ASCO 2026, reinforcing giredestrant’s potential to transform the treatment paradigm in early breast cancer
May 19, 2026
 · 
12 min read
Press Releases
FDA Approves Genentech’s Tecentriq for Adjuvant Muscle-Invasive Bladder Cancer With ctDNA-Guided Treatment
May 17, 2026
 · 
10 min read
Press Releases
Genentech to Present Extensive Data Showcasing Its Industry-Leading Ophthalmology Portfolio at ARVO 2026
April 30, 2026
 · 
15 min read
Press Releases
Roche to present extensive data showcasing its industry-leading ophthalmology portfolio at ARVO 2026
April 30, 2026
 · 
11 min read
Load More